[#DIV28SUPER] NYTimes: A Psychedelics Pioneer Takes the Ultimate Trip

https://www.nytimes.com/interactive/2023/04/03/magazine/roland-griffiths-interview.html?smid=nytcore-ios-share&referringSource=articleShare
A Psychedelics Pioneer Takes the Ultimate Trip


Sent from my iPhone
_____________________ div28SUPER@lists.apa.org _____________________
Div28m members #div28 subscribers corner: http://lists.apa.org

[#DIV28SUPER] FYI - Job opportunity

Begin forwarded message:

From: "Jeffrey Chen" <jeff@radiclescience.com>

Subject: know any biostatisticians for Radicle?

Date: April 3, 2023 at 5:18:24 PM EDT

To: "Ryan Vandrey" <rvandrey@jhmi.edu>

      External Email - Use Caution      

Hi Ryan we are hiring a fulltime biostatistician to lead design and analysis of our clinical trials, and I figured you might know someone!  Here's all the information below to share with anyone who might be a good fit (and feel free to forward this entire email if its easier too).  Thanks so much!  

Radicle Science is a health B-Corp pioneering the category of "Proof-as-a-Service", offering non-pharmaceutical health products history's first easy path to clinically prove their true effects beyond placebo at unprecedented affordability, speed and scale.  We combine gold-standard double-blind, randomized, placebo-controlled design, with a unique AI-driven, crowdsourced, virtual, direct-to-consumer model, to create standardized and automated clinical trials.  In 2022, we were named by KPMG as on of America's Top 10 "Tech Innovators" and by UCSF as a Finalist for their Rising Star Award in Consumer Wellness!

As part of the Research Team, a Senior Biostatistician for Radicle Science is responsible for the analysis and management of study data.  Core tasks include: cleaning and managing study data, database modeling and management, developing mathematical models, conducting statistical analyses, preparing and maintaining technical documentation, preparing tabular and visual formats, assisting with manuscript writing and stakeholder deliverables, and to collaborate with Radicle teams to share best practices and to contribute to process improvement initiatives.  

We are a start-up and growing quickly.  Change is a constant in this start-up, work environment, and everyone pitches in to get the work completed.  Our hours are unconventional and flexible to accommodate collaboration across time zones of our teams and brand partners (clients).  We care about getting the job done, not clocking and clocking out!  So if you are looking for a set schedule of 8 am – 5 pm Monday through Friday, this is probably not a fit for you.

Who are you?

Your experience:

MS in biostatistics, statistics, or related field with 3+ years of experience in human trial research (experience in psychology/mental health research are preferred)

Expertise in longitudinal data analysis and multi-level modeling

Proficient in Stata, SAS and/or R

Work experience using Python (the more the better)

Work experience with large-scale survey data and patient reported outcomes (PROs)

How you work:

You thrive in a fast-paced, start-up environment

You recognize the importance of flexibility in your work environment and can adjust accordingly to those "other duties as assigned" and client meetings as needed

You work well in collaboration and when working autonomously, to bring your ideas back to a team

You are organized and comfortable working in a virtual environment from home

You are a devil with the details but can take a step back and see the bigger picture

You are comfortable using the Google G-suite and/or Microsoft Office suite

Bonus (nice but not required):

Proficiency in Python and Java Script

Experience in machine learning and big data analytics

Experience with the Qualtrics Platform

Here is a general list (not exhaustive) of what a senior biostatistician does at Radicle Science:

Provides statistical and data analytical support to research studies (i.e. power and data analysis)

Participates in the development and management of study timelines and analytical expectations

Ensure consistency in the biostatistical aspects of trial conduct and collaborate with internal team members to maximize efficiencies for research studies

Analysis of study data to identify trends, discrepancies, errors, etc. to inform data driven decision making (DDDM) for study conduct and research efforts

Communicate relevant statistical and analytical information across internal teams, timely communication of urgent information to the appropriate team members, and appropriate escalation of issues to the Chief Research Officer

Participate in maintaining, tracking, management and reporting of study plans and reports

Develop, maintain, and promote positive, effective, and collaborative working relationships with internal team members, with 3rd party vendor personnel, and with co-development partners

Attend company meetings ~4 times per year (quarterly) in Southern California

Identifies areas of best practice and process improvements

Participate in Research Operations initiatives and programs as assigned, including but not limited to the development of SOPs, cross-project initiatives, and training

Maintains awareness and training on applicable regulations, rules, guidance, and SOPs/Work Instructions.

Interested in learning more?  Send your resume to rebel@radicleescience.com.  

Jeff Chen MD/MBA

CEO & Cofounder

626-354-8898

________________

[#DIV28SUPER] Job Opening for Data Science (Neuroinformatics) Program Officer, Division of Neuroscience and Behavior, National Institute on Drug Abuse, NIH

Data Science (Neuroinformatics) Program Officer

Division/Office: 

Division of Neuroscience and Behavior (DNB), Office of the Director

The National Institute on Drug Abuse (NIDA), Division of Neuroscience and Behavior (DNB), Office of the Director is currently recruiting for a data science Program Officer. The mission of the Division of Neuroscience and Behavior is to discover, facilitate and promote outstanding basic animal and human research supporting the mission of NIDA, to identify the causes and consequences of drug addiction and misuse across the lifespan and to guide treatment strategies. DNB develops and supports an extramural research program that will advance the understanding of the genetic, chemical, neurobiological and behavioral mechanisms of addictive drugs and their long-term consequences. Research related to the neurobiological bases of reward and the behaviors that characterize the cycle of addiction are a primary focus of DNB. Additionally, an integral component of DNB’s scientific mission is to grow and maintain a diverse workforce that is dedicated to these research goals and is supported through training initiatives that span from predoctoral level to mid-stage investigator. The Office of the Director directs, coordinates, and supports the Division’s missions and activities through maintaining and evaluating strategic directions and goals, supporting goals through the branch structure, and developing and leveraging collaborations and activities across NIDA and NIH.

The data science Program Officer would be responsible for assisting in the management of a research portfolio of grants using data science approaches to advance science on the causes of consequences of drug use and addiction. Additionally, the grant portfolio would include data curation, sharing, access, reproducibility, security, analysis, harmonization, quality metrics and standards, and visualization. The data science program officer would also serve as a representative for NIDA on NIH-wide and multi-agency committees.

For additional information about this position, please contact Dr. Roger Little, alittle@mail.nih.gov 

Application Submission

For more information and to apply, visit the links below, open March 28^th through April 3^rd, 2023:

Delegated Examining (Open to the Public)

• GS 12/13 Data Scientist

Merit Promotion (Open to Status Candidates)

• GS 12/13 Data Scientist

March 27, 2023

 

 

he National Institute on Drug Abuse at the National Institutes of Health is an agency of the United States Department of Health and Human Services  TO UNSUBSCRIBE: send email to listserv@list.nih.gov Copy and paste UNSUBSCRIBE NIDA_NEURO_SCIENCE-L

 

[#DIV28SUPER] APA Divisions 28 and 55 Psychopharmacology Seminar Series

All,

By way of this e-mail, I want to announce a joint seminar series that will be co-hosted by APA Divisions 28 and 55 focused on psychopharmacology.  The plan is to have a virtual seminar held quarterly each year.  

The first seminar will be held tomorrow, Friday March 31st, at 11am EST.  I will be the guest speaker and will be discussing the human behavioral pharmacology of cannabis.  For anyone interested in attending, here is a link to the seminar:

https://us02web.zoom.us/j/86560361556?pwd=a2FYWnFrNTQ2bFEyb3JFRlU3YU5QUT09 

VERY sorry for the late announcement on this, totally my fault.  I expect that we will get a little better organized with this first seminar taking place and will announce the next speaker with much greater advanced notice and a more fancy advertisement/flyer ;-)  

We are also hoping to arrange for CE credits for this seminar series at some point, but that has not yet been realized for this first session.

If you are interested in being a speaker for one of these events in the future, please e-mail me.

Feel free to share with others who may be interested in attending.

Regards,

-Ryan

________________

Ryan Vandrey, Ph.D.

Past-President

APA Division 28

http://www.apadivisions.org/division-28/index.aspx

[#DIV28SUPER] Postdoctoral training in Alcohol and Addiction Research at the University of Missouri

Postdoctoral Fellowships in Alcohol and Addiction Research
Department of Psychological Sciences
University of Missouri

 

The Department of Psychological Sciences and the Department of Psychiatry at the University of Missouri (MU) are recruiting POSTDOCTORAL RESEARCH FELLOWS IN ALCOHOL AND ADDICTION RESEARCH. Our training grant has been supported by the National Institute of Alcohol Abuse and Alcoholism (NIAAA) since 2002 (T32AA013625; see more here). Positions are available through both the NIH training grant (only US citizens and permanent residents can be considered) and the University of Missouri (no residency limitations).

 

Research mentors include:

• Mary Beth Miller – Health Intervention & Treatment Research Lab (see HIT lab website)
• Sean Lane – Regulation of Emotion, Addiction, and Conflict Trajectories (see REACT lab website)
• Denis McCarthy – Alcohol Cognitions Lab (see website)
• Brett Froeliger – Health Neuroscience Center (see website)
• Bruce Bartholow – Social Cognitive and Addiction Neuroscience Lab (see SCAN lab website)
• Ian Gizer – Gene Brain Behavior Relations Lab
• Clint Davis-Stober – Behavioral Decision-Making Lab (see website)
• Tim Trull – Personality and Emotion Lab (see website)
• Doug Steinley – Multivariate Statistics Lab, with primary interest in cluster analysis and social network analysis

 

 

Postdoctoral research fellows will undertake advanced training in addictions and pursue their own research interests under the supervision of one or more faculty mentors. The goals of the training program are (1) to support the individual development of diverse early career scientists who want to conduct addictions research; (2) to provide hands-on training in grant writing, data analysis, and research design; and (3) to foster collaborative relationships with addiction scientists and community stakeholders locally and across the nation. Positions begin summer 2023 and are available for up to 3 years of training. Fellowship stipends are decided by NIH and based on the status of the fellow; for example, fellows with no prior postdoctoral training start at $54,840 (more detail here). See more about NRSA service payback here.

 

Please submit the following application materials as a single (one) combined PDF to Carol Waudby at waudbyc@missouri.edu:

• Statement of research/training interests – summarize your current interest and expertise, long-term career goals, how postdoctoral training would facilitate those goals, the mentors with whom you would like to work, and how your work incorporates or applies to people of historically underrepresented backgrounds (including but not limited to race, ethnicity, sexual orientation, gender identity, national origin, and the differently abled). The statement should be no longer than 3-4 pages.
• List of 3-5 professional references
• Curriculum vitae

 

Please contact Denis McCarthy at mccarthydm@missouri.edu with questions or concerns. You are also welcome to contact your proposed future research mentor directly.

 

The University of Missouri does not discriminate on the basis of race, color, religion, national origin, ancestry, sex, age, disability, status as disabled veteran, or veteran of Vietnam era.

 

 

 

 

 

Kenneth J. Sher, Ph.D.

Chancellor’s Professor of Psychological Sciences and

Curators’ Distinguished Professor Emeritus

University of Missouri

210 McAlester Hall

Columbia, MO 65211

Tel: 573-268-0006

Email: sherk@missouri.edu

 

[#DIV28SUPER] Division 49 Institute: Developing Diverse and Diversity-Minded Future Leaders

Hi everyone,

I am sending the following message on behalf of Division 49:

We still have space for new members in the Division 49 Institute! The goal of the Institute is to raise attention to the cultural, social, and political contexts that are a part of group psychology and group psychotherapy. By striving to counteract historical oppressions and marginalization, we hope to envision a subdiscipline, and our larger field of psychology, as one that honors and uplifts all people. This can only be accomplished by understanding issues of oppression and marginalization from the perspective of those who are a part of these groups.

Over two years, participants in the Institute will:

Engage in mentorship with Division 49 leaders
Network and develop working relationships with Division 49
Observe and participate in portions of the Division 49 Board meetings including mid-winter meeting and the APA convention
Develop and execute a leadership project that contributes to increasing awareness of issues related to diversity, equity, and inclusion in group psychology and group psychotherapy and present the results at the APA Convention
Reflect and raise one's own awareness of issues related to diversity and social justice and develop skills to continuously engage in cultural humility


Please see our flyer for more information: https://acrobat.adobe.com/link/track?uri=urn:aaid:scds:US:fa938aec-9547-45f7-b07d-4d70e22e981e


To enroll in the Institute, please complete the application found at: https://forms.office.com/r/KKNF6ZFj0Q

_____________________ div28SUPER@lists.apa.org _____________________
Div28m members #div28 subscribers corner: http://lists.apa.org

[#DIV28SUPER] Call for comments - APA's initial decisions in updating the 2017 clinical practice guideline for treatment of PTSD in adults

Dear Division 28 Members,

 

The American Psychological Association (APA) invites you to review and comment on the guideline update panel’s (GUP) initial decisions in updating its 2017 Clinical practice guideline for the treatment of PTSD in adults. The online public comment form is available until 11:59 pm (ET) Friday, April 21, 2023.

 

The GUP has made initial decisions on the framework of the guideline update and systematic reviews of empirical evidence that will be used to develop guideline recommendations (per best practices for guideline development; for further details see Institute of Medicine’s [2011; now National Academy of Medicine] Clinical practice guidelines we can trust) within that scope.

 

The framework is defined in terms of population, intervention, comparator, outcome, timing, and setting (PICOTS) elements.

 

You can access the PDF supporting documents and the online comment form at the following link: https://www.apa.org/about/offices/directorates/guidelines/adults-ptsd-treatment-public-comment

 

Public input on the adequacy of initial guideline decisions is important for maximizing utility of the final guideline for all stakeholders. The GUP carefully considers all comments received and intends to may make modifications to the guideline update process and final recommendations based on these considerations.

 

We would highly value your input given your expertise in this domain. Please forward the announcement to colleagues who may be interested in participating in this opportunity.,

 

If you have any difficulty in accessing or using the online form, please send an email to cpg@apa.org. For more information about APA’s work in developing clinical practice guidelines please click here. Any additional questions may be directed to Raquel Halfond, PhD, Senior Director, Evidence-Based Practice & Health Equity, at rhalfond@apa.org.

 

Thank you!  

 

 

Jacob S. Marzalik, MA (he/him/his)

Project Manager, Clinical Practice Guidelines

Practice Transformation and Quality, Practice Directorate

American Psychological Association

  

750 First Street NE, Washington DC 20002-4242

202-336-5872

 

All APA staff are teleworking until further notice and are experiencing a high volume of inquiries related to COVID-19. For immediate information and resources, visit APA's COVID-19 page for psychologists, health-care workers, and the public.